{"abstracts":[{"sha1":"47bbb2bc9cbafc0de5c96244df20094451e2d189","content":"\nBackground\nEvidence-based guidance for starting ages of screening for first-degree relatives (FDRs) of patients with prostate cancer (PCa) to prevent stage III/IV or fatal PCa is lacking in current PCa screening guidelines. We aimed to provide evidence for risk-adapted starting age of screening for relatives of patients with PCa.\n\n\nMethods and findings\nIn this register-based nationwide cohort study, all men (aged 0 to 96 years at baseline) residing in Sweden who were born after 1931 along with their fathers were included. During the follow-up (1958 to 2015) of 6,343,727 men, 88,999 were diagnosed with stage III/IV PCa or died of PCa. The outcomes were defined as the diagnosis of stage III/IV PCa or death due to PCa, stratified by age at diagnosis. Using 10-year cumulative risk curves, we calculated risk-adapted starting ages of screening for men with different constellations of family history of PCa. The 10-year cumulative risk of stage III/IV or fatal PCa in men at age 50 in the general population (a common recommended starting age of screening) was 0.2%. Men with ≥2 FDRs diagnosed with PCa reached this screening level at age 41 (95% confidence interval (CI): 39 to 44), i.e., 9 years earlier, when the youngest one was diagnosed before age 60; at age 43 (41 to 47), i.e., 7 years earlier, when ≥2 FDRs were diagnosed after age 59, which was similar to that of men with 1 FDR diagnosed before age 60 (41 to 45); and at age 45 (44 to 46), when 1 FDR was diagnosed at age 60 to 69 and 47 (46 to 47), when 1 FDR was diagnosed after age 69. We also calculated risk-adapted starting ages for other benchmark screening ages, such as 45, 55, and 60 years, and compared our findings with those in the guidelines. Study limitations include the lack of genetic data, information on lifestyle, and external validation.\n\n\nConclusions\nOur study provides practical information for risk-tailored starting ages of PCa screening based on nationwide cancer data with valid genealogical information. Our clinically relevant findings could be used for evidence-based personalized PCa screening guidance and supplement current PCa screening guidelines for relatives of patients with PCa.\n","mimetype":"application/xml+jats"}],"refs":[{"index":0,"extra":{"authors":["F Bray"],"doi":"10.3322/caac.21492","volume":"68"},"key":"pmed.1003616.ref001","year":2018,"container_name":"CA Cancer J Clin","title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","locator":"394"},{"index":1,"extra":{"authors":["G Attard"],"doi":"10.1016/s0140-6736(14)61947-4","issue":"10013","volume":"387"},"key":"pmed.1003616.ref002","year":2016,"container_name":"Lancet","title":"Prostate cancer","locator":"70"},{"index":2,"extra":{"authors":["RL Siegel"],"doi":"10.3322/caac.21332","volume":"66"},"key":"pmed.1003616.ref003","year":2016,"container_name":"CA Cancer J Clin","title":"Cancer statistics, 2016"},{"index":3,"extra":{"authors":["VA Moyer"],"doi":"10.7326/0003-4819-157-2-201207170-00459","volume":"157"},"key":"pmed.1003616.ref004","year":2012,"container_name":"Ann Intern Med","title":"Force USPST. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement","locator":"120"},{"index":4,"extra":{"authors":["JC Hu"],"doi":"10.1001/jamaoncol.2016.5465"},"key":"pmed.1003616.ref005","year":2017,"container_name":"JAMA Oncol","title":"Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States","locator":"705"},{"index":5,"extra":{"authors":["SP Kelly"],"doi":"10.1016/j.euf.2017.10.014"},"key":"pmed.1003616.ref006","year":2018,"container_name":"Eur Urol Focus","title":"Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States","locator":"121"},{"index":6,"extra":{"authors":["JN Wu"],"doi":"10.1002/cncr.28485","volume":"120"},"key":"pmed.1003616.ref007","year":2014,"container_name":"Cancer","title":"No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period","locator":"818"},{"index":7,"extra":{"authors":["JJ Fenton"],"doi":"10.1001/jama.2018.3712","issue":"18","volume":"319"},"key":"pmed.1003616.ref008","year":2018,"container_name":"JAMA","title":"Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force","locator":"1914"},{"index":8,"extra":{"authors":["US Preventive Services Task Force"],"doi":"10.1001/jama.2018.3710","issue":"18","volume":"319"},"key":"pmed.1003616.ref009","year":2018,"container_name":"JAMA","title":"Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement","locator":"1901"},{"index":9,"extra":{"authors":["A Brandt"],"doi":"10.1634/theoncologist.2009-0132","issue":"12","volume":"14"},"key":"pmed.1003616.ref010","year":2009,"container_name":"Oncologist","title":"Age at diagnosis and age at death in familial prostate cancer","locator":"1209"},{"index":10,"extra":{"authors":["K Hemminki"],"doi":"10.1002/cncr.10819","volume":"95"},"key":"pmed.1003616.ref011","year":2002,"container_name":"Cancer","title":"Age specific and attributable risks of familial prostate carcinoma from the family-cancer database","locator":"1346"},{"index":11,"extra":{"authors":["N Mottet"],"doi":"10.1016/j.eururo.2016.08.003","volume":"71"},"key":"pmed.1003616.ref012","year":2017,"container_name":"Eur Urol","title":"EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","locator":"618"},{"index":12,"extra":{"authors":["A Qaseem"],"doi":"10.7326/0003-4819-158-10-201305210-00633","issue":"10","volume":"158"},"key":"pmed.1003616.ref013","year":2013,"container_name":"Ann Intern Med","title":"Clinical Guidelines Committee of the American College of P. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians","locator":"761"},{"index":13,"extra":{"authors":["RA Rendon"],"doi":"10.5489/cuaj.4888","issue":"10","volume":"11"},"key":"pmed.1003616.ref014","year":2017,"container_name":"Can Urol Assoc J","title":"Canadian Urological Association recommendations on prostate cancer screening and early diagnosis","locator":"298"},{"index":14,"extra":{"authors":["AM Wolf"],"doi":"10.3322/caac.20066","volume":"60"},"key":"pmed.1003616.ref015","year":2010,"container_name":"CA Cancer J Clin","title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","locator":"70"},{"index":15,"extra":{"authors":["HB Carter"],"doi":"10.1016/j.juro.2013.04.119","volume":"190"},"key":"pmed.1003616.ref016","year":2013,"container_name":"J Urol","title":"Early detection of prostate cancer: AUA Guideline","locator":"419"},{"index":16,"extra":{"authors":["PR Carroll"],"doi":"10.6004/jnccn.2016.0060","volume":"14"},"key":"pmed.1003616.ref017","year":2016,"container_name":"J Natl Compr Cancer Netw","title":"NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016","locator":"509"},{"index":17,"extra":{"authors":["HB Carter"]},"key":"pmed.1003616.ref018","year":2018,"container_name":"Early Detection of Prostate Cancer"},{"index":18,"extra":{"authors":["S Loeb"],"doi":"10.1016/j.eururo.2013.12.062","volume":"65"},"key":"pmed.1003616.ref019","year":2014,"container_name":"Eur Urol","title":"Overdiagnosis and overtreatment of prostate cancer","locator":"1046"},{"index":19,"extra":{"authors":["O Bratt"],"doi":"10.1093/jnci/djq265","issue":"17","volume":"102"},"key":"pmed.1003616.ref020","year":2010,"container_name":"J Natl Cancer Inst","title":"Effects of prostate-specific antigen testing on familial prostate cancer risk estimates","locator":"1336"},{"index":20,"extra":{"authors":["K Hemminki"],"issue":"10","volume":"126"},"key":"pmed.1003616.ref021","year":2010,"container_name":"Int J Cancer","title":"The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies","locator":"2259"},{"index":21,"extra":{"authors":["L Barlow"],"doi":"10.1080/02841860802247664","volume":"48"},"key":"pmed.1003616.ref022","year":2009,"container_name":"Acta Oncol","title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","locator":"27"},{"index":22,"extra":{"authors":["HL Brooke"],"doi":"10.1007/s10654-017-0316-1","volume":"32"},"key":"pmed.1003616.ref023","year":2017,"container_name":"Eur J Epidemiol","title":"The Swedish cause of death register","locator":"765"},{"index":23,"extra":{"unstructured":"Socialstyrelsen. Screening för prostatacancer. Rekommendation och bedömningsunderlag. Sweden: Socialstyrelsen; 2018. Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-screeningprogram/2018-10-15.pdf."},"key":"pmed.1003616.ref024"},{"index":24,"extra":{"unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8 ed: American Joint Committee on Cancer. Springer International Publishing; 2017. XVII, 1032 p."},"key":"pmed.1003616.ref025"},{"index":25,"extra":{"authors":["T Mukama"],"doi":"10.1002/cncr.32815","volume":"126"},"key":"pmed.1003616.ref026","year":2020,"container_name":"Cancer","title":"Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history","locator":"2837"},{"index":26,"extra":{"authors":["P Boyle"],"issue":"95"},"key":"pmed.1003616.ref027","year":1991,"container_name":"IARC Sci Publ","title":"Cancer registration: principles and methods. Statistical methods for registries"},{"index":27,"extra":{"authors":["T Mukama"],"doi":"10.1001/jamaoncol.2019.3876"},"key":"pmed.1003616.ref028","year":2019,"container_name":"JAMA Oncol","title":"Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer","locator":"68"},{"index":28,"extra":{"authors":["Y Tian"],"doi":"10.1053/j.gastro.2020.03.063","volume":"159"},"key":"pmed.1003616.ref029","year":2020,"container_name":"Gastroenterology","title":"Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets"},{"index":29,"extra":{"authors":["T Mukama"],"doi":"10.1016/j.ejca.2019.10.011","volume":"124"},"key":"pmed.1003616.ref030","year":2020,"container_name":"Eur J Cancer","title":"Risk-tailored starting age of breast cancer screening based on women's reproductive profile: A nationwide cohort study","locator":"207"},{"index":30,"extra":{"authors":["EI Benchimol"],"doi":"10.1371/journal.pmed.1001885","issue":"10","volume":"12"},"key":"pmed.1003616.ref031","year":2015,"container_name":"PLoS Med","title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","locator":"e1001885"},{"index":31,"extra":{"authors":["A Brandt"],"doi":"10.1016/j.eururo.2010.02.002","volume":"58"},"key":"pmed.1003616.ref032","year":2010,"container_name":"Eur Urol","title":"Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members","locator":"275"},{"index":32,"extra":{"authors":["F Albright"],"doi":"10.1002/pros.22925","volume":"75"},"key":"pmed.1003616.ref033","year":2015,"container_name":"Prostate","title":"Prostate cancer risk prediction based on complete prostate cancer family history","locator":"390"},{"index":33,"extra":{"authors":["E Kharazmi"],"doi":"10.1136/bmj.e8076","volume":"345"},"key":"pmed.1003616.ref034","year":2012,"container_name":"BMJ","title":"Familial risk of early and late onset cancer: nationwide prospective cohort study","locator":"e8076"},{"index":34,"extra":{"authors":["A Brandt"],"doi":"10.1093/annonc/mdn527","issue":"12","volume":"19"},"key":"pmed.1003616.ref035","year":2008,"container_name":"Ann Oncol","title":"Age of onset in familial cancer","locator":"2084"},{"index":35,"extra":{"authors":["M Bevier"],"doi":"10.1186/1471-2407-11-163","volume":"11"},"key":"pmed.1003616.ref036","year":2011,"container_name":"BMC Cancer","title":"Influence of family size and birth order on risk of cancer: a population-based study","locator":"163"},{"index":36,"extra":{"unstructured":"Rekommendationer om organiserad prostatacancertestning: Regionala cancercentrum i samverkan; 2020. Available from: https://www.cancercentrum.se/samverkan/vara-uppdrag/prevention-och-tidig-upptackt/prostatacancertestning/."},"key":"pmed.1003616.ref037"},{"index":37,"extra":{"authors":["X Xu"],"doi":"10.1002/cncr.33096","issue":"19","volume":"126"},"key":"pmed.1003616.ref038","year":2020,"container_name":"Cancer","title":"Risk of invasive prostate cancer and prostate cancer death in relatives of patients with prostatic borderline or in situ neoplasia: A nationwide cohort study","locator":"4371"},{"index":38,"extra":{"authors":["K Hemminki"],"doi":"10.1093/annonc/mdm414","volume":"19"},"key":"pmed.1003616.ref039","year":2008,"container_name":"Ann Oncol","title":"How common is familial cancer?","locator":"163"},{"index":39,"extra":{"authors":["H Gronberg"],"doi":"10.1016/s0140-6736(03)12713-4","issue":"9360","volume":"361"},"key":"pmed.1003616.ref040","year":2003,"container_name":"Lancet","title":"Prostate cancer epidemiology","locator":"859"},{"index":40,"extra":{"authors":["K Hemminki"],"doi":"10.1007/s00345-011-0801-1","volume":"30"},"key":"pmed.1003616.ref041","year":2012,"container_name":"World J Urol","title":"Familial risk and familial survival in prostate cancer","locator":"143"},{"index":41,"extra":{"authors":["H Jonsson"],"doi":"10.1002/ijc.25846","volume":"129"},"key":"pmed.1003616.ref042","year":2011,"container_name":"Int J Cancer","title":"Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden","locator":"1881"},{"index":42,"extra":{"authors":["AP Enblad"],"volume":"2020"},"key":"pmed.1003616.ref043","container_name":"Scand J Urol","title":"PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing"},{"index":43,"extra":{"authors":["T Nordstrom"],"doi":"10.1016/j.eururo.2012.10.001","volume":"63"},"key":"pmed.1003616.ref044","year":2013,"container_name":"Eur Urol","title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003–2011","locator":"419"},{"index":44,"extra":{"authors":["A Brandt"],"doi":"10.1093/annonc/mdr056","volume":"23"},"key":"pmed.1003616.ref045","year":2012,"container_name":"Ann Oncol","title":"Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer","locator":"251"},{"index":45,"extra":{"authors":["AJ Vickers"],"doi":"10.1038/nrurol.2009.95"},"key":"pmed.1003616.ref046","year":2009,"container_name":"Nat Rev Urol","title":"Prostate cancer: estimating the benefits of PSA screening","locator":"301"},{"index":46,"extra":{"authors":["AJ Vickers"],"doi":"10.1136/bmj.f2023","volume":"346"},"key":"pmed.1003616.ref047","year":2013,"container_name":"BMJ","title":"Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40–55 and long term risk of metastasis: case-control study","locator":"f2023"},{"index":47,"extra":{"authors":["SM Carter"],"doi":"10.1136/bmj.h869","volume":"350"},"key":"pmed.1003616.ref048","year":2015,"container_name":"BMJ","title":"The challenge of overdiagnosis begins with its definition","locator":"h869"},{"index":48,"extra":{"authors":["J Hugosson"],"doi":"10.1016/j.eururo.2019.02.009","volume":"76"},"key":"pmed.1003616.ref049","year":2019,"container_name":"Eur Urol","title":"A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer","locator":"43"},{"index":49,"extra":{"authors":["ME Wood"],"doi":"10.1200/jco.2013.51.4661","volume":"32"},"key":"pmed.1003616.ref050","year":2014,"container_name":"J Clin Oncol","title":"Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative","locator":"824"},{"index":50,"extra":{"authors":["KH Lu"],"doi":"10.1200/jco.2013.50.9257","volume":"32"},"key":"pmed.1003616.ref051","year":2014,"container_name":"J Clin Oncol","title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","locator":"833"},{"index":51,"extra":{"authors":["K Clift"],"doi":"10.1200/jco.2019.37.15_suppl.e13161","issue":"15_suppl","volume":"37"},"key":"pmed.1003616.ref052","year":2019,"container_name":"J Clin Oncol","title":"Enhanced family history screening is crucial to individualized cancer surveillance"},{"index":52,"extra":{"authors":["N Qureshi"],"doi":"10.1097/gim.0b013e3181a7e8e0","volume":"11"},"key":"pmed.1003616.ref053","year":2009,"container_name":"Genet Med","title":"The current state of cancer family history collection tools in primary care: a systematic review","locator":"495"},{"index":53,"extra":{"authors":["GS Ginsburg"],"doi":"10.1016/s0140-6736(19)31275-9","issue":"10198","volume":"394"},"key":"pmed.1003616.ref054","year":2019,"container_name":"Lancet","title":"Family health history: underused for actionable risk assessment","locator":"596"}],"contribs":[{"index":0,"creator_id":"udbvgziqbbh4lacfcb6ipbeb3u","creator":{"orcid":"0000-0001-8381-3012","surname":"Xu","given_name":"Xing","display_name":"Xing Xu","state":"active","ident":"udbvgziqbbh4lacfcb6ipbeb3u","revision":"a16d9db1-04be-4c38-9e00-4da30d4946a7"},"raw_name":"Xing Xu","given_name":"Xing","surname":"Xu","role":"author","extra":{"seq":"first"}},{"index":1,"raw_name":"Elham Kharazmi","given_name":"Elham","surname":"Kharazmi","role":"author"},{"index":2,"creator_id":"kmrwgzymfbdjbeptygt3g2g7ia","creator":{"orcid":"0000-0001-7218-5954","surname":"Tian","given_name":"Yu","display_name":"Yu Tian","state":"active","ident":"kmrwgzymfbdjbeptygt3g2g7ia","revision":"e4e33815-1f7d-4289-b6c3-e4dff5bbb1b7"},"raw_name":"Yu Tian","given_name":"Yu","surname":"Tian","role":"author"},{"index":3,"creator_id":"b5wv7ptgqnco5cipalgh7faj5u","creator":{"orcid":"0000-0002-6520-5272","surname":"Mukama","given_name":"Trasias","display_name":"Trasias Mukama","state":"active","ident":"b5wv7ptgqnco5cipalgh7faj5u","revision":"cde1e520-e8bf-4b6e-8d62-ca89b186ec79"},"raw_name":"Trasias Mukama","given_name":"Trasias","surname":"Mukama","role":"author"},{"index":4,"creator_id":"b3pmot3xzrgmvkzw4ydfjgbdvy","creator":{"orcid":"0000-0001-8031-279X","surname":"Kristina","given_name":"Sundquist","display_name":"Sundquist Kristina","state":"active","ident":"b3pmot3xzrgmvkzw4ydfjgbdvy","revision":"f4cc8059-da76-4172-82f6-39d3495eac45"},"raw_name":"Kristina Sundquist","given_name":"Kristina","surname":"Sundquist","role":"author"},{"index":5,"creator_id":"56gj54xlfjb73mumzk7cwvwhsu","creator":{"orcid":"0000-0001-7228-5015","surname":"Sundquist","given_name":"Jan","display_name":"Jan Sundquist","state":"active","ident":"56gj54xlfjb73mumzk7cwvwhsu","revision":"2fa469f0-f68c-45ee-ba2b-3233e9d8cb8e"},"raw_name":"Jan Sundquist","given_name":"Jan","surname":"Sundquist","role":"author"},{"index":6,"creator_id":"m3ody4ghqbbtnjwnewvx4ewnsu","creator":{"orcid":"0000-0002-6129-1572","surname":"Brenner","given_name":"Hermann","display_name":"Hermann Brenner","state":"active","ident":"m3ody4ghqbbtnjwnewvx4ewnsu","revision":"b8af263e-a3f1-4142-8463-0c96784fc0ce"},"raw_name":"Hermann Brenner","given_name":"Hermann","surname":"Brenner","role":"author"},{"index":7,"creator_id":"dglvquhstvevdg4yp2w46pcmem","creator":{"orcid":"0000-0002-6639-065X","surname":"Fallah","given_name":"Mahdi","display_name":"Mahdi Fallah, MD, PhD","state":"active","ident":"dglvquhstvevdg4yp2w46pcmem","revision":"c3a26a81-1b08-4b8b-9f2c-e6088ed2650d"},"raw_name":"Mahdi Fallah","given_name":"Mahdi","surname":"Fallah","role":"author"},{"raw_name":"Paul Pinsky","given_name":"Paul","surname":"Pinsky","role":"editor","extra":{"seq":"first"}}],"license_slug":"CC-BY","language":"en","publisher":"Public Library of Science (PLoS)","pages":"e1003616","issue":"6","volume":"18","ext_ids":{"doi":"10.1371/journal.pmed.1003616","pmid":"34061847"},"release_year":2021,"release_date":"2021-06-01","release_stage":"published","release_type":"article-journal","container_id":"iznnn644szdwva7khyxqzc73bi","webcaptures":[],"filesets":[],"files":[{"release_ids":["n5naxnaz3zhh7iqigsljtnfhcm"],"mimetype":"application/pdf","urls":[{"url":"https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pmed.1003616/1/pmed.1003616.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210611%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210611T074139Z&X-Goog-Expires=86400&X-Goog-SignedHeaders=host&X-Goog-Signature=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","rel":"publisher"},{"url":"https://web.archive.org/web/20210611074139/https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pmed.1003616/1/pmed.1003616.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210611%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210611T074139Z&X-Goog-Expires=86400&X-Goog-SignedHeaders=host&X-Goog-Signature=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","rel":"webarchive"}],"sha256":"92f778e25dd5ebed89caf5a6e8ba9141bc3c61f7090e85f63700f9e0f041ab5e","sha1":"8ef08a31f759068fce2584b9c3ada43acb3e0227","md5":"1fec5013f0115379f0962faa600722ef","size":946823,"revision":"a826f56e-2a6b-478e-865d-86e873045216","ident":"ge3lprmvkzekha2mf5z22qje4i","state":"active"}],"container":{"wikidata_qid":"Q1686921","issnp":"1549-1277","issne":"1549-1676","issnl":"1549-1277","publisher":"Public Library of Science","container_type":"journal","name":"PLoS Medicine","extra":{"abbrev":"PLoS Med.","country":"us","default_license":"CC-BY","doaj":{"archive":["PMC"],"as_of":"2022-07-06","default_license":"CC-BY","seal":true},"kbart":{"lockss":{"year_spans":[[2004,2009]]}},"languages":["en"],"publisher_type":"oa","road":{"as_of":"2018-01-24"},"sherpa_romeo":{"color":"green"},"urls":["https://journals.plos.org/plosmedicine/","http://www.plosmedicine.org/"]},"revision":"6511f755-9fb2-471e-8e54-f9dddcc83658","ident":"iznnn644szdwva7khyxqzc73bi","state":"active"},"work_id":"nbd2utwhujemro6kfzydojkxdm","title":"Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study","state":"active","ident":"n5naxnaz3zhh7iqigsljtnfhcm","revision":"05447024-cc9d-4f42-a48b-0cd8723bf51e","extra":{"crossref":{"funder":[{"DOI":"10.13039/501100004543","award":[],"doi-asserted-by":"publisher","name":"China Scholarship Council"},{"DOI":"10.13039/501100004359","award":["2020-01175","2018-02400"],"doi-asserted-by":"crossref","name":"Vetenskapsrådet"}],"license":[{"URL":"http://creativecommons.org/licenses/by/4.0/","content-version":"vor","delay-in-days":0,"start":"2021-06-01T00:00:00Z"}],"subject":["General Medicine"],"type":"journal-article"},"pubmed":{"pub_types":["Journal Article"]}}}